title: High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria.
abstract: BACKGROUND
  Others have reported a clear distinction between patients with primary hyperparathyroidism (PHPT) and normal subjects using the intact PTH (iPTH) assay.
  
  
  OBJECTIVE
  We reviewed our last 60 surgically proven cases of PHPT, who had adequate preoperative biochemical assessment, to determine the usefulness of the iPTH assay, ionised calcium and other biochemical criteria in differentiating between normal subjects and patients with PHPT.
  
  
  METHODS
  We conducted a retrospective cross-sectional study of all patients with surgically proven PHPT who had been referred to Sir Charles Gairdner Hospital, Perth, Western Australia for preoperative biochemical assessment. All cases had fasting preoperative blood and urine samples collected for ionised calcium, plasma total calcium, albumin, urine calcium excretion, renal phosphate threshold and iPTH.
  
  
  RESULTS
  Fifty cases had a single or double adenoma and ten had hyperplasia. All except one had ionised hypercalcaemia but only 47 (78%) had an elevated corrected total calcium (cCa). Therefore 13 cases (22%) had a normal cCa and five of those patients (8%) had both an iPTH and cCa within the reference range. Forty-nine (82%) had an elevated ionised calcium (iCa) and iPTH; the remaining 11 (18%) had an iPTH within the reference range. Of this latter 18%, ten (91%) had a low renal phosphate threshold and five (45%) had significant renal calcium conservation: all 11 cases had at least one abnormality in the renal handling of calcium or phosphate and all normalised their plasma calcium postoperatively (ionised and corrected total calcium).
  
  
  CONCLUSIONS
  One in five patients with proven PHPT have a non-elevated cCa and/or intact PTH. Ionised calcium should be measured in all suspected cases. Additional studies of renal calcium and phosphate handling are helpful to establish a diagnosis where any uncertainty exists.
authors.affiliation: Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, WA.
authors.forename: P
authors.initials: P
authors.lastname: Glendenning
authors.forename: D H
authors.initials: DH
authors.lastname: Gutteridge
authors.forename: R W
authors.initials: RW
authors.lastname: Retallack
authors.forename: B G
authors.initials: BG
authors.lastname: Stuckey
authors.forename: D G
authors.initials: DG
authors.lastname: Kermode
authors.forename: G N
authors.initials: GN
authors.lastname: Kent
mesh_terms: D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000097:blood*; D007668:Kidney / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D010710:Phosphates / Q000378:metabolism; D012189:Retrospective Studies
chemical_list: D010281:Parathyroid Hormone; D010710:Phosphates; D002118:Calcium